Aptinyx Inc. (APTX) NASDAQ

$2.82 0.17 (6.42%)

Market Cap: $190.96M

As of 01/20/22 04:00 PM EST. Market closed.

(APTX)

Aptinyx Inc. (APTX) NASDAQ

$2.82 0.17 (6.42%)

Market Cap: $190.96M

As of 01/20/22 04:00 PM EST. Market closed.

Aptinyx Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx has a platform for discovery of novel compounds that work through a unique mechanism to modulate-rather than block or over-activate-NMDA receptors and enhance synaptic ... read more

Aptinyx Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx has a platform for discovery of novel compounds that work through a unique mechanism to modulate-rather than block or over-activate-NMDA receptors and enhance synaptic plasticity, the foundation of neural cell communication. The company has three product candidates in clinical development in central nervous system indications, including chronic pain, post-traumatic stress disorder, and cognitive impairment associated with Parkinson's disease. Aptinyx is also advancing additional compounds from its proprietary discovery platform, which continues to generate a rich and diverse pipeline of small-molecule NMDA receptor modulators with the potential to treat an array of neurologic disorders. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$452,509
CEO Compensation (Total)
$10.61M
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
34
CEO Compensation (Base)
$452,509
CEO Compensation (Total)
$10.61M
Address
.
KEY STATS
Open
$2.62
Previous Close
$2.65
Days Range
$2.60 - $2.82
52 week range
$2.06 - $4.73
Volume
136,789
Avg. Volume (30 days)
138,190
Market Cap
$190.96M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
67,715,718
Open
$2.62
Previous Close
$2.65
Days Range
$2.60 - $2.82
52 week range
$2.06 - $4.73
Volume
136,789
Avg. Volume (30 days)
138,190
Market Cap
$190.96M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
67,715,718

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR APTINYX INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Miller Joan W. Director Jan 13, 2022 Buy $2.83 17,700 50,091 17,700 Jan 18, 2022, 04:19 PM
RIEDEL NORBERT G CEO Dec 06, 2021 Buy $2.23 100,000 223,000 100,000 Dec 08, 2021, 04:16 PM
KHANNA ASHISH CFO AND CBO Dec 02, 2021 Buy $2.26 45,000 101,700 420,040 Dec 06, 2021, 04:16 PM
HOMBACH ROBERT J. Director Nov 12, 2021 Buy $2.40 74,600 179,040 229,100 Nov 16, 2021, 05:58 PM
HOMBACH ROBERT J. Director Nov 11, 2021 Buy $2.40 5,400 12,960 154,500 Nov 16, 2021, 05:58 PM
HOMBACH ROBERT J. Director Nov 11, 2021 Buy $2.40 5,400 12,960 144,500 Nov 15, 2021, 06:37 PM
HOMBACH ROBERT J. Director Nov 12, 2021 Buy $2.40 74,600 179,040 219,100 Nov 15, 2021, 06:37 PM
RIEDEL NORBERT G CEO May 17, 2021 Option Exercise $2.53 127,274 322,003 615,265 May 19, 2021, 06:46 PM
Bain Capital Life Sciences Investors, LLC 10% Owner Oct 26, 2020 Buy $3.00 3,333,333 9,999,999 8,891,758 Oct 27, 2020, 05:07 PM
Topper James N Director Mar 31, 2020 Option Exercise $2.16 4,976 10,748 3,195,055 Apr 02, 2020, 04:32 PM
Sherman Rachel E. Director Jan 22, 2020 Buy $4.79 2,174 10,413 2,174 Jan 23, 2020, 05:44 PM
Koppel Adam Director Jan 14, 2020 Buy $3.00 3,333,333 9,999,999 5,558,425 Jan 16, 2020, 04:20 PM
ADAMS STREET PARTNERS LLC 10% Owner Jan 10, 2020 Buy $3.00 1,000,000 3,000,000 1,465,716 Jan 14, 2020, 05:05 PM
RIEDEL NORBERT G CEO and President Jan 10, 2020 Buy $3.00 35,000 105,000 35,000 Jan 14, 2020, 04:23 PM
HOMBACH ROBERT J. Director Jan 10, 2020 Buy $3.00 50,000 150,000 139,100 Jan 14, 2020, 04:21 PM
Gosebruch Henry O Director Jan 10, 2020 Buy $3.00 25,000 75,000 125,000 Jan 14, 2020, 04:19 PM
ENRIGHT PATRICK G Director Jan 10, 2020 Buy $3.00 166,667 500,001 3,356,746 Jan 14, 2020, 04:16 PM
ENRIGHT PATRICK G Director Jan 10, 2020 Buy $3.00 95,000 285,000 95,000 Jan 14, 2020, 04:16 PM
HOMBACH ROBERT J. Director Nov 22, 2019 Buy $3.23 50,000 161,750 89,100 Nov 26, 2019, 04:12 PM
Gosebruch Henry O Director May 08, 2019 Buy $3.86 96,580 372,799 100,000 May 09, 2019, 10:01 AM
Gosebruch Henry O Director May 07, 2019 Buy $3.75 3,420 12,825 3,420 May 09, 2019, 10:01 AM
Madsen Torsten M. Chief Medical Officer Jan 28, 2019 Buy $5.27 1,050 5,533 232,600 Jan 30, 2019, 06:58 PM
HOMBACH ROBERT J. Director Jan 25, 2019 Buy $5.54 11,655 64,569 49,100 Jan 28, 2019, 06:12 PM
HOMBACH ROBERT J. Director Jan 24, 2019 Buy $5.52 13,345 73,664 37,445 Jan 28, 2019, 06:12 PM
KHANNA ASHISH CFO and CBO Jan 18, 2019 Buy $5.45 10,000 54,500 283,130 Jan 18, 2019, 08:38 PM
RIEDEL NORBERT G CEO and President Nov 12, 2018 Option Exercise $2.59 38,563 99,878 362,539 Nov 14, 2018, 04:16 PM
New Leaf Venture Management III, L.L.C. 10% Owner Jun 25, 2018 Buy $16.00 250,000 4,000,000 2,921,734 Jun 26, 2018, 04:57 PM
Frazier Life Sciences VIII, L.P. 10% Owner Jun 25, 2018 Buy $16.00 150,000 2,400,000 3,190,079 Jun 26, 2018, 04:56 PM
HOMBACH ROBERT J. Director Jun 25, 2018 Buy $16.00 24,100 385,600 24,100 Jun 26, 2018, 04:55 PM
Longitude Capital Partners II, LLC 10% Owner Jun 25, 2018 Buy $16.00 150,000 2,400,000 3,190,079 Jun 26, 2018, 04:55 PM
Topper James N Director Jun 25, 2018 Buy $16.00 150,000 2,400,000 3,190,079 Jun 26, 2018, 04:54 PM
Ratcliffe Liam Director Jun 25, 2018 Buy $16.00 250,000 4,000,000 2,921,734 Jun 26, 2018, 04:53 PM
Koppel Adam Director Jun 25, 2018 Buy $16.00 400,000 6,400,000 2,225,092 Jun 26, 2018, 04:50 PM
Gould Terry P Director Jun 25, 2018 Buy $16.00 150,000 2,400,000 1,115,910 Jun 26, 2018, 04:50 PM
ENRIGHT PATRICK G Director Jun 25, 2018 Buy $16.00 150,000 2,400,000 3,190,079 Jun 26, 2018, 04:49 PM
GANTZ WILBUR H Director Jun 25, 2018 Buy $16.00 23,100 369,600 372,514 Jun 26, 2018, 04:49 PM
MOSKAL JOSEPH R. Chief Scientific Officer Jun 25, 2018 Buy $16.00 3,000 48,000 378,288 Jun 26, 2018, 04:47 PM
Madsen Torsten M. Chief Medical Officer Jun 25, 2018 Buy $16.00 1,000 16,000 231,550 Jun 26, 2018, 04:47 PM
KIDD ANDREW Chief Commercial Officer Jun 25, 2018 Buy $16.00 6,700 107,200 9,133 Jun 26, 2018, 04:45 PM
KHANNA ASHISH CFO and CBO Jun 25, 2018 Buy $16.00 1,800 28,800 1,800 Jun 26, 2018, 04:44 PM
KHANNA ASHISH CFO and CBO Jun 25, 2018 Buy $16.00 6,000 96,000 273,130 Jun 26, 2018, 04:44 PM
RIEDEL NORBERT G CEO and President Jun 25, 2018 Buy $16.00 2,400 38,400 5,118 Jun 26, 2018, 04:44 PM
ADAMS STREET PARTNERS LLC 10% Owner Jun 25, 2018 Buy $16.00 150,000 2,400,000 1,115,910 Jun 26, 2018, 04:44 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Miller Joan W. Director 01/13/2022 50,091
RIEDEL NORBERT G CEO 12/06/2021 223,000
KHANNA ASHISH CFO AND CBO 12/02/2021 101,700
HOMBACH ROBERT J. Director 11/12/2021 179,040
HOMBACH ROBERT J. Director 11/11/2021 12,960
HOMBACH ROBERT J. Director 11/11/2021 12,960
HOMBACH ROBERT J. Director 11/12/2021 179,040
RIEDEL NORBERT G CEO 05/17/2021 322,003
Bain Capital Life Sciences Investors, LLC 10% Owner 10/26/2020 9,999,999
Topper James N Director 03/31/2020 10,748
Sherman Rachel E. Director 01/22/2020 10,413
Koppel Adam Director 01/14/2020 9,999,999
ADAMS STREET PARTNERS LLC 10% Owner 01/10/2020 3,000,000
RIEDEL NORBERT G CEO and President 01/10/2020 105,000
HOMBACH ROBERT J. Director 01/10/2020 150,000
Gosebruch Henry O Director 01/10/2020 75,000
ENRIGHT PATRICK G Director 01/10/2020 500,001
ENRIGHT PATRICK G Director 01/10/2020 285,000
HOMBACH ROBERT J. Director 11/22/2019 161,750
Gosebruch Henry O Director 05/08/2019 372,799
Gosebruch Henry O Director 05/07/2019 12,825
Madsen Torsten M. Chief Medical Officer 01/28/2019 5,533
HOMBACH ROBERT J. Director 01/25/2019 64,569
HOMBACH ROBERT J. Director 01/24/2019 73,664
KHANNA ASHISH CFO and CBO 01/18/2019 54,500
RIEDEL NORBERT G CEO and President 11/12/2018 99,878
New Leaf Venture Management III, L.L.C. 10% Owner 06/25/2018 4,000,000
Frazier Life Sciences VIII, L.P. 10% Owner 06/25/2018 2,400,000
HOMBACH ROBERT J. Director 06/25/2018 385,600
Longitude Capital Partners II, LLC 10% Owner 06/25/2018 2,400,000
Topper James N Director 06/25/2018 2,400,000
Ratcliffe Liam Director 06/25/2018 4,000,000
Koppel Adam Director 06/25/2018 6,400,000
Gould Terry P Director 06/25/2018 2,400,000
ENRIGHT PATRICK G Director 06/25/2018 2,400,000
GANTZ WILBUR H Director 06/25/2018 369,600
MOSKAL JOSEPH R. Chief Scientific Officer 06/25/2018 48,000
Madsen Torsten M. Chief Medical Officer 06/25/2018 16,000
KIDD ANDREW Chief Commercial Officer 06/25/2018 107,200
KHANNA ASHISH CFO and CBO 06/25/2018 28,800
KHANNA ASHISH CFO and CBO 06/25/2018 96,000
RIEDEL NORBERT G CEO and President 06/25/2018 38,400
ADAMS STREET PARTNERS LLC 10% Owner 06/25/2018 2,400,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2021
06/30/2021
0.51%
1Q
09/30/2021
03/31/2021
1.53%
2Q
09/30/2021
12/31/2020
37.22%
3Q
09/30/2021
09/30/2020
47.36%
4Q
09/30/2021
06/30/2020
49.82%
5Q
Load More

Period of Report: 09/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
0.51%
1Q
03/31/2021
1.53%
2Q
12/31/2020
37.22%
3Q
09/30/2020
47.36%
4Q
06/30/2020
49.82%
5Q
Load More